Arsen Karapetyan

FDA investigator · also recorded as Cle Arsen Karapetyan, Fee Arsen Karapetyan

Appears on 43 documents from 2014 to 2025, most often at sites in India. Most often cites responsibilities of quality control unit (21 CFR 211.22).

43
Documents on file
5.5
Observations per 483
2014
First seen
2025
Most recent

What they cite most

From 235 observations

Activity by year

2014: 1, 2017: 2, 2018: 2, 2019: 5, 2021: 5, 2022: 11, 2023: 8, 2024: 5, 2025: 4

Where

India 17 · China 5 · Japan 4 · Spain 3 · Bangladesh 2 · Canada 2

Is Arsen Karapetyan coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

43 documents, newest first
FirmOpen
483 A. Nelson & Co., Ltd.Sep 19, 2025 · London, United Kingdom
483 Dr. Reddy's Laboratories (EU) Ltd. Steanard LaneSep 5, 2025 · Mirfield, United Kingdom
483 NATCO Pharma LimitedJun 19, 2025 · Rangareddy, India
483 SOFTGEL HEALTHCARE PRIVATE LIMITEDFeb 14, 2025 · Chengalpattu, India
483 VIVA PHARMACEUTICAL INC.Oct 25, 2024 · Richmond, Canada
483 Cosmaceutical Research Laboratory IncOct 12, 2024 · Surrey, Canada
483 SRIKEM LABORATORIES PRIVATE LIMITEDMay 31, 2024 · Navi Mumbai, India

About this profile

What does Arsen Karapetyan inspect?

Arsen Karapetyan appears on 43 documents on file covering 39 sites, most often in India.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.192 and 21 CFR 211.68.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Arsen Karapetyan is dated Sep 19, 2025.